CNBX Pharmaceuticals Inc. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: CNBX Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q4 2024.
CNBX Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending November 30, 2024 was -$36.8K, a 78.6% increase year-over-year.
CNBX Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending November 30, 2024 was -$448K, a 40.8% increase year-over-year.
CNBX Pharmaceuticals Inc. annual Operating Income (Loss) for 2024 was -$583K, a 37.4% increase from 2023.
CNBX Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$931K, a 68.5% increase from 2022.
CNBX Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$2.95M, a 13.6% decline from 2021.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2024	-$448K	-$36.8K	+$135K	+78.6%	Sep 1, 2024	Nov 30, 2024	10-Q	2025-01-13
Q3 2024	-$583K	-$52.5K	+$109K	+67.5%	Jun 1, 2024	Aug 31, 2024	10-K	2024-11-29
Q2 2024	-$692K	-$152K	+$20.8K	+12%	Mar 1, 2024	May 31, 2024	10-Q	2024-07-15
Q1 2024	-$713K	-$206K	+$43.6K	+17.4%	Dec 1, 2023	Feb 29, 2024	10-Q	2024-04-16
Q4 2023	-$756K	-$172K	+$175K	+50.4%	Sep 1, 2023	Nov 30, 2023	10-Q	2025-01-13
Q3 2023	-$931K	-$161K	+$317K	+66.2%	Jun 1, 2023	Aug 31, 2023	10-K	2024-11-29
Q2 2023	-$1.25M	-$173K	+$462K	+72.7%	Mar 1, 2023	May 31, 2023	10-Q	2024-07-15
Q1 2023	-$1.71M	-$250K	+$480K	+65.8%	Dec 1, 2022	Feb 28, 2023	10-Q	2024-04-16
Q4 2022	-$2.19M	-$347K	+$764K	+68.8%	Sep 1, 2022	Nov 30, 2022	10-Q	2024-01-12
Q3 2022	-$2.95M	-$478K	+$118K	+19.8%	Jun 1, 2022	Aug 31, 2022	10-K	2023-11-30
Q2 2022	-$3.07M	-$635K	+$41.2K	+6.1%	Mar 1, 2022	May 31, 2022	10-Q	2023-07-14
Q1 2022	-$3.11M	-$730K	-$62.4K	-9.34%	Dec 1, 2021	Feb 28, 2022	10-Q	2023-04-14
Q4 2021	-$3.05M	-$1.11M	-$451K	-68.3%	Sep 1, 2021	Nov 30, 2021	10-Q	2023-01-13
Q3 2021	-$2.6M	-$596K	+$74.4K	+11.1%	Jun 1, 2021	Aug 31, 2021	10-K	2022-11-30
Q2 2021	-$2.67M	-$676K	+$14.3K	+2.07%	Mar 1, 2021	May 31, 2021	10-Q	2022-07-14
Q1 2021	-$2.69M	-$668K	+$198K	+22.9%	Dec 1, 2020	Feb 28, 2021	10-Q	2022-04-12
Q4 2020	-$2.89M	-$660K	+$156K	+19.1%	Sep 1, 2020	Nov 30, 2020	10-Q	2022-01-13
Q3 2020	-$3.04M	-$671K	+$309K	+31.5%	Jun 1, 2020	Aug 31, 2020	10-K	2021-11-29
Q2 2020	-$3.35M	-$691K	+$89K	+11.4%	Mar 1, 2020	May 31, 2020	10-Q	2021-07-14
Q1 2020	-$3.44M	-$866K	+$29.7K	+3.31%	Dec 1, 2019	Feb 29, 2020	10-Q	2021-04-14
Q4 2019	-$3.47M	-$816K	-$168K	-25.8%	Sep 1, 2019	Nov 30, 2019	10-Q	2021-01-14
Q3 2019	-$3.3M	-$980K	-$261K	-36.3%	Jun 1, 2019	Aug 31, 2019	10-K	2020-11-04
Q2 2019	-$3.04M	-$780K	+$72.2K	+8.48%	Mar 1, 2019	May 31, 2019	10-Q	2020-07-14
Q1 2019	-$3.11M	-$896K	+$805K	+47.3%	Dec 1, 2018	Feb 28, 2019	10-Q	2020-04-13
Q4 2018	-$3.92M	-$648K	-$111K	-20.7%	Sep 1, 2018	Nov 30, 2018	10-Q	2020-01-14
Q3 2018	-$3.81M	-$719K	+$367K	+33.8%	Jun 1, 2018	Aug 31, 2018	10-K	2019-11-29
Q2 2018	-$4.18M	-$852K	-$379K	-80.1%	Mar 1, 2018	May 31, 2018	10-Q	2019-07-15
Q1 2018	-$3.8M	-$1.7M	-$1.51M	-784%	Dec 1, 2017	Feb 28, 2018	10-Q	2019-04-15
Q4 2017	-$2.29M	-$537K	-$434K	-422%	Sep 1, 2017	Nov 30, 2017	10-Q	2019-01-17
Q3 2017	-$1.85M	-$1.09M	-$1.01M	-1317%	Jun 1, 2017	Aug 31, 2017	10-K	2018-11-29
Q2 2017	-$845K	-$473K	-$459K	-3316%	Mar 1, 2017	May 31, 2017	10-Q	2018-07-16
Q1 2017	-$386K	-$193K	-$55.3K	-40.2%	Dec 1, 2016	Feb 28, 2017	10-Q	2018-04-05
Q4 2016	-$331K	-$103K	-$49.9K	-94.3%	Sep 1, 2016	Nov 30, 2016	10-Q	2018-01-16
Q3 2016	-$281K	-$76.6K	+$166K	+68.4%	Jun 1, 2016	Aug 31, 2016	10-K	2017-12-08
Q2 2016	-$447K	-$13.8K	+$140K	+91%	Mar 1, 2016	May 31, 2016	10-Q	2017-07-17
Q1 2016	-$587K	-$137K	-$80.7K	-143%	Dec 1, 2015	Feb 29, 2016	10-Q	2017-04-14
Q4 2015	-$506K	-$52.9K	+$30.7K	+36.7%	Sep 1, 2015	Nov 30, 2015	10-Q	2017-01-17
Q3 2015	-$537K	-$242K	-$74.7K	-44.6%	Jun 1, 2015	Aug 31, 2015	10-K	2016-12-13
Q2 2015	-$462K	-$154K	-$149K	-3096%	Mar 1, 2015	May 31, 2015	10-Q	2016-07-13
Q1 2015	-$313K	-$56.6K	-$27.2K	-92.8%	Dec 1, 2014	Feb 28, 2015	10-Q	2016-04-18
Q4 2014	-$285K	-$83.6K	-$69.4K	-488%	Sep 1, 2014	Nov 30, 2014	10-Q/A	2016-04-08
Q3 2014	-$216K	-$168K			Jun 1, 2014	Aug 31, 2014	10-K	2016-01-07
Q2 2014		-$4.81K	-$102	-2.17%	Mar 1, 2014	May 31, 2014	10-Q/A	2015-11-17
Q1 2014		-$29.3K			Dec 1, 2013	Feb 28, 2014	10-Q/A	2015-11-17
Q4 2013		-$14.2K			Sep 1, 2013	Nov 30, 2013	10-Q/A	2015-11-17
Q2 2013		-$4.71K			Mar 1, 2013	May 31, 2013	10-Q/A	2014-07-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.